Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 33-0903864 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Scientific Research focusing on development of preventative and therapeutic treatments for both infectious (maalaria, Hepatitis b and c, and Influenza) and non-infectious diseases (cancer and cardiovascular disease).
Principal Officer
David Whitacre
Total Revenue
$665K
FY2024
Total Expenses
$625K
FY2024
Net Assets
$5K
Program Ratio
69.9%
expenses on programs
Employees
4
Volunteers
—
Board Members
3
Voting
0
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.